Tim Greten
MD
Head, GI Malignancies Section
👥Biography 个人简介
Tim Greten at NCI leads translational and early phase clinical research in hepatocellular carcinoma and biliary tract cancers. His research has been pivotal in establishing immunotherapy in liver cancer, including early trials of tremelimumab in HCC and the HIMALAYA trial of tremelimumab plus durvalumab. His work on combination immunotherapy in liver cancers continues to advance the field.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Tim Greten 的研究动态
Follow Tim Greten's research updates
留下邮箱，当我们发布与 Tim Greten（National Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment